Loading...
GlucoTrack, Inc.
GCTK•NASDAQ
Healthcare
Medical - Instruments & Supplies
$6.60
$-1.24(-15.82%)
GlucoTrack, Inc. (GCTK) Financial Performance & Statements
Review GlucoTrack, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-104.77%
↓ 104.77%
Net Income Growth
418.40%
↑ 418.40%
Operating Cash Flow Growth
-90.45%
↓ 90.45%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
393.38%
↑ 393.38%
ROIC
-345.60%
↓ 345.60%
GlucoTrack, Inc. (GCTK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for GlucoTrack, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $12000.00 | $0.00 | $8000.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$8000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $1.87M | $1.70M | $2.06M | $3.59M |
| SG&A Expenses | $1.63M | $2.13M | $1.19M | $902000.00 |
| Operating Expenses | $3.50M | $25.24M | -$3.25M | $4.49M |
| Total Costs & Expenses | $0.00 | $25.24M | -$3.25M | $4.49M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $14000.00 | $10000.00 | $8000.00 |
| EBITDA | $0.00 | -$10.08M | -$3.24M | -$4.48M |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | -$25.24M | $3.25M | -$4.49M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $0.00 | $15.15M | -$8.34M | $2000.00 |
| Income Before Tax | $6.83M | -$10.09M | -$5.09M | -$4.49M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $39276.00 | $0.00 | $0.00 |
| Net Income | $6.83M | -$10.09M | -$5.09M | -$4.49M |
| Net Income Ratio | ||||
| EPS | -$0.67 | -$21.75 | -$18.18 | -$16.40 |
| Diluted EPS | -$0.67 | -$21.75 | -$18.18 | -$16.40 |
| Weighted Avg Shares Outstanding | $371910.00 | $330171.00 | $279000.00 | $273000.00 |
| Weighted Avg Shares Outstanding (Diluted) | $371910.00 | $330171.00 | $279744.00 | $273787.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan